A pilot study to investigate adherence to long-acting opioids among patients with advanced lung cancer

Journal of Palliative Medicine

Volumn 16, Issue 4, 2013, Pages 391-396

  Yoong, Jaclyn ^a   Traeger, Lara N ^b   Gallagher, Emily R ^b   Pirl, William F ^b   Greer, Joseph A ^b   Temel, Jennifer S ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; METHADONE; MORPHINE SULFATE; OXYCODONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; FEASIBILITY STUDY; FEMALE; GROUPS BY AGE; HUMAN; KNOWLEDGE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PILOT STUDY; PRESCRIPTION; QUESTIONNAIRE; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; BOSTON; CROSS-SECTIONAL STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PILOT PROJECTS;

EID: 84875850777     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2012.0400     Document Type: Article

References (56)

1. Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations).
2. Bethesda, MD: National Cancer Institute. Based on November 2011 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975-2009- pops09/ (Last accessed May 30, 2012).
3. Davis MP, Walsh D: Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004;21:137-142.
4. Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
5. Deandrea S, Montanari M, Moja L, et al: Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008;19:1985-1991.
6. Enting RH, Oldenmenger WH, Van Gool AR, et al: The effects of analgesic prescription and patient adherence on pain in a Dutch outpatient cancer population. J Pain Symptom Manage 2007;34:523-531.
7. Mitera G, Fairchild A, DeAngelis C, et al: A multicenter assessment of the adequacy of cancer pain treatment using the pain management index. J Palliat Med 2010;13:589-593.
8. Portenoy RK, Lesage P: Management of cancer pain. Lancet 1999;353:1695-1700.
9. Setoguchi S, Earle CC, Glynn R, et al: Comparison of prospective and retrospective indicators of the quality of endof- life cancer care. J Clin Oncol 2008;26:5671-5678.
10. Simone CB II, Vapiwala N, Hampshire MK, et al: Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain 2012;28:157-162.
11. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al: Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007;18:1437-1449.
12. Du Pen SL, Du Pen AR, Polissar N, et al: Implementing guidelines for cancer pain management: Results of a randomized controlled clinical trial. J Clin Oncol 1999;17:361-370.
13. Purcell WT, Grossman SA, Carson KA: High outpatient pain scores identify patients at high risk for inpatient hospital admission. Proc Am Soc Clin Oncol 2003;22:(abstr 2963).
14. Wagner-Johnston ND, Carson KA, Grossman SA: High outpatient pain intensity scores predict impending hospital admissions in patients with cancer. J Pain Symptom Manage 2010;39:180-185.
15. Apolone G, Corli O, Caraceni A, et al: Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 2009;100:1566-1574.
16. Ferrell BR, Juarez G, Borneman T: Use of routine and breakthrough analgesia in home care. Oncol Nurs Forum 1999;26:1655-1661.
17. Jerant A, Franks P, Tancredi DJ, et al: Tendency to adhere to provider-recommended treatments and subsequent pain severity among individuals with cancer. Patient Prefer Adherence 2011;5:23-31.
18. Marinangeli F, Ciccozzi A, Leonardis M, et al: Use of strong opioids in advanced cancer pain: A randomized trial. J Pain Symptom Manage 2004;27:409-416.
19. Miaskowski C, Dodd MJ, West C, et al: Lack of adherence with the analgesic regimen: A significant barrier to effective cancer pain management. J Clin Oncol 2001;19:4275-4279.
20. Oldenmenger WH, Echteld MA, de Wit R, et al: Analgesic adherence measurement in cancer patients: Comparison between electronic monitoring and diary. J Pain Symptom Manage 2007;34:639-647.
21. Valeberg BT, Miaskowski C, Hanestad BR, et al: Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications. Clin J Pain 2008;24:627-636.
22. Zech DF, Grond S, Lynch J, et al: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain 1995;63:65-76.
23. World Health Organization: Adherence to Long-term Therapies: Evidence for Action. Geneva: World Health Organization, 2003.
24. Abbas SQ, Abbas Z: Is opiate compliance a problem in cancer pain? A survey of health-care professionals' views. Int J Palliat Nurs 2003;9:56-63.
25. Haynes RB, McDonald HP, Garg AX: Helping patients follow prescribed treatment: Clinical applications. JAMA 2002;288:2880-2883.
26. McDonnell PJ, Jacobs MR: Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-1336.
27. Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005;353:487-497.
28. Senst BL, Achusim LE, Genest RP, et al: Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001;58:1126-1132.
29. Sokol MC, McGuigan KA, Verbrugge RR, et al: Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-530.
30. Delgado-Guay MO, Bruera E: Management of pain in the older person with cancer. Oncology (Williston Park) 2008;22:56-61.
31. Fahey KF, Rao SM, Douglas MK, et al: Nurse coaching to explore and modify patient attitudinal barriers interfering with effective cancer pain management. Oncol Nurs Forum 2008;35:233-240.
32. Pargeon KL, Hailey BJ: Barriers to effective cancer pain management: A review of the literature. J Pain Symptom Manage 1999;18:358-368.
33. Sun VC, Borneman T, Ferrell B, et al: Overcoming barriers to cancer pain management: An institutional change model. J Pain Symptom Manage 2007;34:359-369.
34. Ward SE, Goldberg N, Miller-McCauley V, et al: Patientrelated barriers to management of cancer pain. Pain 1993;52:319-324.
35. Ward SE, Wang KK, Serlin RC, et al: A randomized trial of a tailored barriers intervention for Cancer Information Service (CIS) callers in pain. Pain 2009;144:49-56.
36. Pirl WF: Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr 2004;32:32-39.
37. Cashman SB, Savageau JA, Lemay CA, et al: Patient health status and appointment keeping in an urban community health center. J Health Care Poor Underserved 2004;15:474-488.
38. Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090; discussion 1073.
39. Hugen PW, Langebeek N, Burger DM, et al: Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr 2002;30:324-334.
40. Liu H, Golin CE, Miller LG, et al: A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977.
41. Lu M, Safren SA, Skolnik PR, et al: Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 2008;12:86-94.
42. Shi L, Liu J, Fonseca V, et al: Correlation between adherence rates measured by MEMS and self-reported questionnaires: A meta-analysis. Health Qual Life Outcomes 2010;8:99.
43. Shi L, Liu J, Koleva Y, et al: Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010;28:1097-1107.
44. Walsh JC, Mandalia S, Gazzard BG: Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002;16:269-277.
45. Gjerdingen D, Crow S, McGovern P, et al: Postpartum depression screening at well-child visits: Validity of a 2-question screen and the PHQ-9. Ann Fam Med 2009;7:63-70.
46. Kroenke K, Spitzer RL, Williams JB: The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
47. Kroenke K, Spitzer RL, Williams JB: The Patient Health Questionnaire-2: Validity of a two-item depression screener. Med Care 2003;41:1284-292.
48. Li C, Friedman B, Conwell Y, et al: Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc 2007;55:596-602.
49. Lowe B, Kroenke K, Grafe K: Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005;58:163-171.
50. Whooley MA, Avins AL, Miranda J, et al: Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439-445.
51. Gordon DB, Dahl JL, Miaskowski C, et al: American Pain Society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574-1580.
52. Centers for Disease Control and Prevention. FastStats. Cancer. www.cdc.gov/nchs/fastats/cancer.htm (Last accessed May 29, 2012).
53. Ciaramella A, Poli P: Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psychooncology 2001;10:156-165.
54. Spiegel D, Sands S, Koopman C: Pain and depression in patients with cancer. Cancer 1994;74:2570-2578.
55. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107.
56. Walsh D, Donnelly S, Rybicki L: The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000;8:175-179.